PROPYL-THYRACIL TABLET

Riik: Kanada

keel: inglise

Allikas: Health Canada

Osta kohe

Laadi alla Toote omadused (SPC)
06-04-2020

Toimeaine:

PROPYLTHIOURACIL

Saadav alates:

PALADIN LABS INC.

ATC kood:

H03BA02

INN (Rahvusvaheline Nimetus):

PROPYLTHIOURACIL

Annus:

100MG

Ravimvorm:

TABLET

Koostis:

PROPYLTHIOURACIL 100MG

Manustamisviis:

ORAL

Ühikuid pakis:

100

Retsepti tüüp:

Prescription

Terapeutiline ala:

ANTITHYROID AGENTS

Toote kokkuvõte:

Active ingredient group (AIG) number: 0103603002; AHFS:

Volitamisolek:

CANCELLED POST MARKET

Loa andmise kuupäev:

2020-04-07

Toote omadused

                                PRESCRIBING INFORMATION
Pr
PROPYL-THYRACIL
®
(propylthiouracil tablets USP)
Thyroid Inhibitor
Paladin Labs Inc.
Date of Revision:
100 Alexis-Nihon Blvd, Suite 600
April 6, 2020
Saint-Laurent, Quebec, Canada
H4M 2P2
Squire Pharmaceuticals Inc..
611
Control No.: 233767
2
PRESCRIBING INFORMATION
Pr
PROPYL-THYRACIL
®
(propylthiouracil tablets USP)
Thyroid Inhibitor
ACTION
Propylthiouracil affects the synthesis of thyroid hormones by
inhibiting the incorporation of
iodide into thyroglobulin. It does not inactivate thyroid hormones
previously formed or interfere
with their release from the gland.
Also, depending on the activity of the disease and on whether or not
the patient has previously
received iodide, the clinical effects will not appear until the stored
supply of thyroid hormones
has been utilized.
Clinical response may be delayed for up to two weeks. Propylthiouracil
may also decrease the
rate of conversion of T
4
(1-thyroxine) to T
3
(triiodothyronine) in peripheral tissues.
Iodide uptake is not decreased by propylthiouracil.
In responsive patients, prolonged remission may be obtained only after
several months of
treatment and may take up to several years. The average duration of
treatment is usually one
year.
Data suggest that stopping therapy as soon as the euthyroid state is
attained is as effective in
some patients as continuing therapy for a year or longer.
3
INDICATIONS
Propylthiouracil is indicated:
1.
For the medical management of hyperthyroidism.
2.
In conjunction with radioiodine to hasten recovery while awaiting the
effects of radiation.
3.
For control of thyrotoxicosis prior to surgery.
4.
In the management of a thyroid storm in addition to other therapeutic
measures.
CONTRAINDICATIONS
Hypersensitivity or idiosyncratic reaction to propylthiouracil.
Nursing mothers.
WARNINGS
SERIOUS WARNINGS AND PRECAUTIONS
Liver toxicity (see Hepatic Function section below)
HEPATIC FUNCTION: Liver injury resulting in liver failure, liver
transplantation, or death, has been
reported with propylthiouracil therapy i
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Toote omadused Toote omadused prantsuse 06-04-2020